Seventy-nine patients with metastatic breast cancer underwent examination of their bone marrow as part of their staging workup. Thirty-one (3%) showed no evidence of bone marrow involvement (BM-); 48 (61%) were found to have bone marrow metastases (BM+). Both groups of patients were treated with int
PREDICTION OF BONE STRENGTH FOR METASTATIC BREAST CANCER TO BONE
โ Scribed by John Lee; Sarah Arrington; Erica Fisher; Timothy Damron; Matthew Allen; Kenneth Mann
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 118 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0021-9290
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The estrogen receptor (ER) profile of patients with breast cancer metastatic to bone marrow (BM) has not been widely reported. The charts of all patients having a diagnosis of breast cancer and undergoing bone marrow aspiration or biopsy at the Cleveland Clinic during the period of January 1980 thro
The time to detection of metastatic bone disease (MBD) by radiographic examination was studied in 221 patients with advanced breast cancer. None of the patients had bone metastases by radiography or bone marrow carcinosis, evaluated by bilateral iliac crest biopsy. The period of follow-up after firs